The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Molina Healthcare Inc

NYSE: MOH
Last

(U.S.) $54.14

Today's change-0.56 -1.02%
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.
 

Molina Healthcare Inc

NYSE: MOH
Last

(U.S.) $54.14

Today's change-0.56 -1.02%
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.

Molina Healthcare Inc down (U.S.)$0.56

Molina Healthcare Inc closed lower Friday, dropping (U.S.)$0.56 or 1.02% to (U.S.)$54.14. Over the last five days, shares have lost 3.56% and are down 9.96% for the last year to date. This security has underperformed the S&P 500 by 39.14% during the last year.

Key company metrics

  • Open(U.S.) $54.69
  • Previous close(U.S.) $54.70
  • High(U.S.) $54.94
  • Low(U.S.) $53.67
  • Bid / Ask-- / --
  • YTD % change-9.96%
  • Volume471,831
  • Average volume (10-day)613,359
  • Average volume (1-month)901,901
  • Average volume (3-month)1,181,294
  • 52-week range(U.S.) $44.50 to (U.S.) $81.95
  • Beta1.65
  • Trailing P/E23.67×
  • P/E 1 year forward19.93×
  • Forward PEG1.13×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.29
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+0.82%

Based on its net profit margin of 0.82%, Molina Healthcare Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.06%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue4,3594,3433,8713,611
Total other revenue--------
Total revenue4,3594,3433,8713,611
Gross profit649628568561
Total cost of revenue3,7103,7153,3033,050
Total operating expense4,2544,2543,7943,499
Selling / general / administrative510507463423
Research & development--------
Depreciation / amortization34322826
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income1058976113
Interest income (expense), net non-operating-25-25-21-15
Gain (loss) on sale of assets--------
Other--------
Income before tax80645698
Income after tax33243046
Income tax, total47402751
Net income33243046
Total adjustments to net income--------
Net income before extra. items33243046
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items33243046
Inc. avail. to common incl. extra. items33243046
Diluted net income33243046
Dilution adjustment--------
Diluted weighted average shares55576060
Diluted EPS excluding extraordinary itemsvalue per share0.600.420.490.77
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.600.420.490.77